Finance Pfizer buys monthly GLP-1RA developer Metsera for $4.9bnSeptember 22, 20250 Pfizer has acquired Metsera for $4.9bn, because the drugmaker targets longer-lasting glucagon-like peptide-1 receptor agonists (GLP-1RAs) to cement market share…
